PCM
BHC icon

Prelude Capital Management’s Bausch Health BHC Stock Holding History

Prelude Capital Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-155,000
Closed -$4.28M – 1836
2021
Q4 		$4.28M Sell
155,000
-37,500
-19% -$1M 0.11% 118
2021
Q3 		$5.36M Buy
192,500
+69,400
+56% +$1.97M 0.14% 86
2021
Q2 		$3.67M Sell
123,100
-61,900
-33% -$1.88M 0.11% 127
2021
Q1 		$5.87M Buy
185,000
+92,600
+100% +$2.72M 0.15% 89
2020
Q4 		$1.92M Buy
+92,400
New +$1.72M 0.05% 307
2020
Q3 		– Sell
-800
Closed -$15K – 1834
2020
Q2 		$15K Sell
800
-46,800
-98% -$825K ﹤0.01% 1455
2020
Q1 		$738K Buy
47,600
+46,800
+5,850% +$1.13M 0.05% 259
2019
Q4 		$24K Buy
+800
New +$20.8K ﹤0.01% 1541
2016
Q4 		– Sell
-18,000
Closed -$442K – 1549
2016
Q3 		$442K Buy
+18,000
New +$466K 0.05% 339
2015
Q4 		– Sell
-2,000
Closed -$357K – 1453
2015
Q3 		$357K Buy
+2,000
New +$466K 0.05% 372
2014
Q3 		– Sell
-58,600
Closed -$7.39M – 1864
2014
Q2 		$7.39M Buy
58,600
+29,200
+99% +$3.73M 0.98% 5
2014
Q1 		$3.88M Buy
+29,400
New +$4.02M 0.52% 16

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return

Prelude Capital Management's BHC Position: Q3 2020 in Review

Prelude Capital Management sold out of Bausch Health (BHC) in Q3 2020, closing a stake of 1,648 shares — an estimated $30K sold.

Prelude Capital Management first reported a position in BHC in Q3 2013 and held it in 18 quarters. The position peaked at $2.79M in Q4 2013. 324 funds tracked by Wall St. Rank hold BHC as of Q3 2020.

  • Prelude Capital Management reported no remaining Bausch Health position as of Q3 2020 after selling out during the quarter.
  • Prelude Capital Management sold 1,648 Bausch Health shares in Q3 2020, an estimated $30K.
  • Prelude Capital Management first reported a position in Bausch Health in Q3 2013 and held it in 18 quarters.
  • Prelude Capital Management's Bausch Health position peaked at $2.79M in Q4 2013.
  • 324 funds tracked by Wall St. Rank held Bausch Health as of Q3 2020.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.